Abstract: The present disclosure relates to a battery management apparatus and method, which sets a degraded SOC region based on a SOC-based voltage difference between a charging voltage and a discharging voltage according to a SOC of a battery and estimates a degree of degradation of the battery based on the voltage difference in the set degraded SOC region.

Abstract: The present invention relates to a novel Bifidobacterium bifidum MG731 strain and a composition for preventing or treating cancers, comprising the same. Specifically, the Bifidobacterium bifidum MG731 strain of the present invention has effects of inhibiting the proliferation of cancer cells, decreasing the mobility of cancer cells, inhibiting the neoangiogenesis, and increasing the anticancer immune response as well as reducing the expression of inflammatory factors, thereby having effects of preventing or treating cancers or inflammatory diseases. In addition, when used in combination with an anticancer chemotherapeutic agent or an anticancer immunotherapeutic agent, the Bifidobacterium bifidum MG731 strain of the present invention exhibits a better anticancer effect. In addition, the present invention relates to a novel Lactococcus lactis GEN3033 strain and a composition for preventing or treating cancers, comprising the same.

Abstract: The present invention relates to a composition for promoting the efficiency of somatic cell replication, comprising endothelin as an active ingredient. When somatic cells are treated with the composition of the present invention, H3K9me3, which is suspected to be a factor for the lowering success rate of nuclear substitution, is inhibited, and H3K4me3, which has the opposite effect, is increased to increase the success rate of nuclear substitution. Accordingly, the composition of the present invention increases the efficiency of somatic cell replication, thereby increasing the efficiency of producing pluripotent stem cells derived from nuclear substitution, and ultimately, the composition is expected to contribute to the development of cell therapeutic agents.

Abstract: The present invention provides a method of manufacturing n battery cells (n?2), each including a respective reference electrode for measuring a relative electrode potential, including: (i) manufacturing a reference cell composed of an electrolyte solution, the reference electrodes, and a lithium electrode; (ii) charging the reference cell; (iii) charging the reference cell to 40% to 60% of a capacity discharged in the process (ii), thereby performing formation on the reference electrodes; (iv) manufacturing the n battery cells, each of the battery cells including a respective one of the reference electrodes, an electrode assembly, the electrolyte solution and a battery case; and (v) in each of the battery cells, measuring a relative potential of the respective one of the reference electrodes and a positive electrode of the respective electrode assembly, and a relative potential of the respective one of the reference electrodes and a negative electrode of the respective electrode assembly.

Abstract: An apparatus and method are provided for forming a pouch case with improved forming quality and minimized surface contact between the forming apparatus and the pouch case in the forming process to form a pouch cup. The apparatus includes a mold on which a pouch case with a plate shape can be placed, wherein the mold bulges upwards, a chamber open at bottom to the pouch case and the mold, the chamber having an inner space in which the mold can be received by lift-up of the mold or lift-down of the chamber, wherein the chamber is seated on an edge portion of the pouch case, and the chamber is equipped with a fluid input valve at top and a fluid output valve at bottom, and a fluid supply unit configured to supply a fluid via the fluid input valve to carry out pressure forming of the pouch case.

Abstract: A display device includes a substrate having a display area and a non-display area located at an outer periphery of the display area; a transistor layer disposed on the substrate; a plurality of partition walls disposed on the transistor layer in the display area; a light emitting element disposed between the partition walls; and a spacer configured to be disposed in the non-display area of the substrate, wherein the spacer may include a spacer body disposed on the same layer as the partition walls and on at least a portion of the transistor layer.

Abstract: A method of preparing an electrode for a secondary battery including: (a) a process of partially coating an electrode slurry containing an electrode mixture and a solvent on an electrode sheet so that coated portions are positioned with an uncoated portion interposed therebetween; (b) a process of drying the coated portions to remove the solvent; and (c) a process of rolling the dried coated portions, wherein a thickness of the coated portion is decreased and the electrode mixture moves to the uncoated portions, resulting in the coated portions disappearing, in the process (c).

Abstract: The present invention relates to an electrode assembly including at least two electrode plates and a separator interposed between the electrode plates, wherein indented portions are formed from lower ends of opposite sides of the electrode tab in an opposite direction to an externally extending direction of the electrode tab in a side of the electrode body in which the electrode tab externally extends, in the electrode plates.

Abstract: A central safety management apparatus includes a safety management unit collecting safety management policies and regulations for each energy source and calculating operation criteria for each energy source; an accident precursor analysis unit collecting accident event related information of each energy source from a plurality of energy source safety management apparatuses managing different energy sources and analyzing occurrence possibility of safety accidents in advance based on the accident event related information and the operation criteria; and a safety enforcement unit transmitting a result of the analysis of the accident precursor analysis unit to the plurality of energy source safety management apparatuses.

Abstract: A negative electrode including: a current collector; a first negative electrode active material layer positioned on at least one surface of the current collector for a negative electrode and containing a first carbonaceous active material; and a second negative electrode active material layer positioned on a surface of the first negative electrode active material layer and containing a silicon-based active material and carbon nanotubes. A lithium secondary battery including the negative electrode is also disclosed.

Abstract: Disclosed herein is a battery case configured to receive an electrode assembly and an electrolytic solution therein, the electrode assembly including a positive electrode, a negative electrode, and a separator interposed between the positive electrode and the negative electrode, the battery case including a layer structure and a gas adsorption layer formed on the inner surface of the layer structure, the gas adsorption layer including a gas adsorption material layer configured to adsorb a reaction gas that may be generated within the battery case during abnormal functioning of the electrode assembly, and and a blocking layer formed on an exposed surface of the gas adsorption material layer, the blocking layer configured to prevent the gas adsorption material layer from being exposed to an ambient gas during assembly of the battery case.

Abstract: Provided are a protein complex in which estrogen receptor 2 (ERT2) is fused to CRISPR associated protein 9 (Cas9), and a recombinant vector carrying a gene coding the protein complex, wherein ERT2 is bonded to the N-terminus and C-terminus of nuclear localization sequence (NLS)-removed Cas9 and the complex has the advantage of translocating from the cytosol into the nucleus at a certain time point upon treatment with tamoxifen and modifying a specific DNA with the aid of guide RNA (gRNA), ultimately enabling a more elaborate DNA modification operation in a desired part at a desired time point.

Abstract: The present invention relates to a method for predicting susceptibility to sorafenib treatment by using an SULF2 gene, and a composition for treatment of sorafenib-resistant cancer using the SULF2 expression inhibition. The method for predicting susceptibility to sorafenib treatment by using the SULF2 gene according to the present invention can enable achievement of an optimal therapeutic effect by administering a drug suitable for cancer patients, and the composition for treatment of sorafenib-resistant cancer using the SULF2 inhibition has a very excellent anticancer treatment effect.

Abstract: A cloud system for a big data process, and an operation method thereof. A cloud operation method of processing big data includes: receiving a cluster rule; monitoring a cluster resource and a cluster task; adding a cluster resource based on the cluster rule and a cluster resource monitoring value; and replicating a cluster based on a cluster rule and a cluster task monitoring value, wherein the cluster rule may include at least one of a resource assignment threshold value, a resource amount to be assigned, a task threshold value, and a number of replicated clusters.

Abstract: An electronic device for executing a plurality of applications and a method for controlling the electronic device are provided. The method includes determining a first application related to an acquired user input from among the plurality of applications, and executing a task corresponding to the user input in the first application.

Abstract: A method for activating a battery cell. The battery cell includes a positive electrode coated with a nickel cobalt manganese (NCM) positive electrode material, into which lithium nickel oxide (LNO) has been added or mixed. The method includes a step of charging the battery cell; and a step of discharging the battery cell, when, in the step of charging the battery cell, the battery cell is charged under a charging condition of C-rate of 0.1 C to 0.5 C in a state of being heated at a temperature of 45° C. to 60° C. When the activation process is performed according to the present invention having the above-described configuration, the pressing/heating conditions for suppressing generation of a gas may be provided to prevent swelling, battery deformation, and performance deterioration due to the generation of the gas from occurring.

Abstract: A display device includes a substrate having a display area and a non-display area located at an outer periphery of the display area; a transistor layer disposed on the substrate; a plurality of partition walls disposed on the transistor layer in the display area; a light emitting element disposed between the partition walls; and a spacer configured to be disposed in the non-display area of the substrate, wherein the spacer may include a spacer body disposed on the same layer as the partition walls and on at least a portion of the transistor layer.

Abstract: Disclosed is an apparatus for passenger recognition and boarding/alighting support of an autonomous vehicle. An apparatus for passenger recognition and boarding/alighting support of an autonomous vehicle according to an embodiment of the present disclosure may include a vehicle communicator configured to receive scheduled passenger information, a sensor configured to sense people outside the vehicle, and a vehicle controller configured to extract a passenger candidate group by analyzing the sensed people outside the vehicle, and calculate the number of reserved passengers using the extracted passenger candidate group and the received scheduled passenger information. One or more of an autonomous vehicle, a server, and a terminal of the present disclosure may be associated or combined with an artificial intelligence module, a drone (Unmanned Aerial Vehicle, UAV), a robot, an AR (Augmented Reality) device, a VR (Virtual Reality) device, a device associated with 5G network services, etc.

Abstract: An embodiment of the present disclosure is, as a multi-purpose autonomous vehicle control apparatus for controlling an autonomous vehicle having a receiving space and an external display and for providing a shuttling operation for driving along a predetermined route, the multi-purpose autonomous vehicle control apparatus including a communicator for receiving a vehicle operation request signal, and a controller for generating a mode designation signal for designating a vehicle operation mode corresponding to the vehicle use purpose, and the communicator transmits the mode designation signal to the autonomous vehicle. At least one among an autonomous driving vehicle, a user terminal, and a server according to embodiments of the present disclosure may be associated or integrated with an artificial intelligence module, a drone (unmanned aerial vehicle (UAV)), a robot, an augmented reality (AR) device, a virtual reality (VR) device, a 5G service related device, and the like.

Abstract: The present invention relates to a composition for preventing and treating liver fibrosis or cirrhosis and, more specifically, to a pharmaceutical composition for preventing and treating liver fibrosis or cirrhosis, comprising an expression or activity enhancer of transcriptional intermediary factor 1 gamma (TIF1?) as an active ingredient, and a method for screening the same. The pharmaceutical composition for preventing or treating liver fibrosis or cirrhosis, comprising an expression or activity enhancer of TIF1? as an active ingredient, according to the present invention, inhibits the activity of hepatic stellate cells (HSCs) and decreases the expression of ?-SMA proteins or the secretion of collagen Type I, thereby ultimately being expected to be developed as a prophylactic or therapeutic agent for liver fibrosis or cirrhosis. In addition, the composition of the present invention is expected to be useful in a method for screening an agent for liver fibrosis or cirrhosis.